<DOC>
	<DOC>NCT00768521</DOC>
	<brief_summary>This study will design an alternative urodynamic platform to better evaluate treatment effects of medications for overactive bladder. Part II is dependent on results of Part I and may not be conducted.</brief_summary>
	<brief_title>A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Patient is a postmenopausal female 40 to 75 years of age Patient has a Body Mass Index (BMI) less than or equal to 35 kg/m2 Patient has a documented history of overactive bladder for at least 6 months prior to screening Patient has stress or mixed incontinence Patient has a history of interstitial cystitis, painful bladder syndrome, or chronic pelvic pain Patient has a history of stroke, seizures, or major neurological disorders Patient has a history of fecal incontinence Patient has a history of continual urine leakage Patient has had surgery to correct stress urinary incontinence or pelvic organ prolapse within 6 months of study start Patient received bladder training of electrostimulation within 2 weeks of study start Patient requires a catheter Patient is taking medications that cannot be stopped for the duration of the trial including certain anticholinergics or smooth muscle relaxants Patient began taking tricyclic antidepressants, serotonin/norepinephrine reuptake inhibitors, calcium channel blockers, ephedrine/pseudoephedrine, or diuretic therapy less than 8 weeks before study start Patient has been on hormone replacement therapy for less than 12 weeks at study start Patient must take medication for arrhythmia Patient consumes more than 2 alcoholic beverages per day Patient consumes more than 3 servings of caffeinated beverages per day (1 serving = 120 mg caffeine) Patient has multiple and/or severe allergies to foods and drugs Patient regularly uses any illegal drugs</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>